Trials / Completed
CompletedNCT04305899
A Study to Compare the Taste and Levels in Blood Plasma of BMS-986165 When Taken as Different Formulations by Healthy Adult Participants
An Open-Label Cross-Over Study to Compare Bioavailability, Dose Proportionality, and Palatability of Single Doses of BMS-986165 Minitablet Pediatric Formulation in Fasted and Fed Conditions Relative to Single Doses of BMS-986165 Clinical Formulations In Healthy Adult Participants
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 40 (actual)
- Sponsor
- Bristol-Myers Squibb · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to compare the taste, and the levels in blood plasma of different tablet formulations of BMS-986165 when taken by healthy adults.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | BMS-986165 Tablet formulation 1 | Specified dose on specified days |
| DRUG | BMS-986165 Tablet formulation 2 | Specified dose on specified days |
Timeline
- Start date
- 2020-08-31
- Primary completion
- 2020-11-25
- Completion
- 2020-11-25
- First posted
- 2020-03-12
- Last updated
- 2021-11-11
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04305899. Inclusion in this directory is not an endorsement.